NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

This Biopharma Company Has A Better 6-Month Return Than AMD, Nvidia, Ford, Wells Fargo And Bank Of America

Published 27/03/2022, 18:51
© Reuters This Biopharma Company Has A Better 6-Month Return Than AMD, Nvidia, Ford, Wells Fargo And Bank Of America
BAC
-
F
-
NVDA
-
WFC
-
AMD
-
ABBV
-
NVDC34
-

AbbVie Inc (NYSE: NYSE:ABBV) is one of the world’s largest pharmaceutical companies, and over the past year, has delivered eye-popping returns for investors.

Since September 2021, AbbVie stock’s 6-month return has outperformed several of the world’s most popular tech, EV and financial services stocks: Advanced Micro Devices, Inc. (NASDAQ: NASDAQ:AMD), NVIDIA Corporation (NASDAQ: NASDAQ:NVDA), Ford Motor Company (NYSE: NYSE:F), Wells Fargo & Co (NYSE: NYSE:WFC) and Bank of America Corp (NYSE: NYSE:BAC).

AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents close to half of the company's current profits.

AbbVie was spun off from Abbott in early 2013. The recent acquisition of Allergan (NYSE:AGN) adds several new drugs in aesthetics and women's health. AbbVie was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Here's how the returns break down from September 2021 to present:

  • AMD is up from $108.16 to $119.67 for a return of 10.64%
  • Nvidia is up from $216.60 to $276.92 for a return of 27.85%
  • Ford is up from $14.16 to $16.47 for a return of 16.31%
  • Wells Fargo is up from $47.56 to $52.56 for a return of 10.51%
  • Bank of America is up from $43.26 to $43.73 for a return of 1.09%
And finally, AbbVie is up from $107.72 to $161.33 for a return of 49.77%

Also See: This Steel Company Has A Better 1-Year Return Than Tesla, Lucid, Apple (NASDAQ:AAPL), Microsoft (NASDAQ:MSFT), Bitcoin Cash And Ethereum

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.